Armistice Capital’s Affirm AFRM Stock Holding History

Armistice Capital’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,536	Closed	-$1.28M	–	366
2025 Q3	$1.28M	Buy	+17,536	New	+$1.33M	0.02%	158

Other funds holding AFRM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Armistice Capital's AFRM Position: Q4 2025 in Review

Armistice Capital sold out of Affirm (AFRM) in Q4 2025, closing a stake of 17,536 shares — an estimated $1.28M sold.

Armistice Capital first reported a position in AFRM in Q3 2025 and held it in 1 quarter. The position peaked at $1.28M in Q3 2025. 640 funds tracked by Wall St. Rank hold AFRM as of Q4 2025.

Armistice Capital reported no remaining Affirm position as of Q4 2025 after selling out during the quarter.
Armistice Capital sold 17,536 Affirm shares in Q4 2025, an estimated $1.28M.
Armistice Capital first reported a position in Affirm in Q3 2025 and held it in 1 quarter.
Armistice Capital's Affirm position peaked at $1.28M in Q3 2025.
640 funds tracked by Wall St. Rank held Affirm as of Q4 2025.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.